Patents by Inventor Xiaolin Bai
Xiaolin Bai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220151984Abstract: A pharmaceutical composition is prepared from the following raw materials (in parts by weight): silybin (8.75-60), phospholipid (15-65), a Pu'er tea extract (25-200), and vitamin E (6.25-40). The composition has the effect of treating non-alcoholic fatty liver diseases.Type: ApplicationFiled: January 28, 2022Publication date: May 19, 2022Applicant: TASLY PHARMACEUTICAL GROUP CO., LTD.Inventors: He SUN, Xijun YAN, Naifeng WU, Kaijing YAN, Yonghong ZHU, Shunnan ZHANG, Xiaolin BAI, Xiaohui MA, Yi HE, Ting LI, Lei LI
-
Patent number: 11318112Abstract: A pharmaceutical composition is prepared from the following raw materials (in parts by weight): silybin (8.75-60), phospholipid (15-65), a Pu'er tea extract (25-200), and vitamin E (6.25-40). The composition has the effect of treating non-alcoholic fatty liver diseases.Type: GrantFiled: March 22, 2016Date of Patent: May 3, 2022Assignee: TASLY PHARMACEUTICAL GROUP CO., LTD.Inventors: He Sun, Xijun Yan, Naifeng Wu, Kaijing Yan, Yonghong Zhu, Shunnan Zhang, Xiaolin Bai, Xiaohui Ma, Yi He, Ting Li, Lei Li
-
Patent number: 10507197Abstract: Disclosed is a pharmaceutical composition containing silibinin, which is prepared from the following bulk drugs by weight ratio: 8.75-60 parts of silibinin, 15-65 parts of phospholipid, and 25-200 parts of Pu'er tea extract. The drug has the function of treating non-alcoholic fatty liver.Type: GrantFiled: March 22, 2016Date of Patent: December 17, 2019Assignee: Tasly Pharmaceutical Group Co., Ltd.Inventors: Naifeng Wu, Xijun Yan, He Sun, Kaijing Yan, Yonghong Zhu, Shunnan Zhang, Xiaolin Bai, Yi He, Xiaohui Ma, Ting Li, Lei Li
-
Patent number: 10376491Abstract: Disclosed are a pharmaceutical composition for treating non-alcoholic fatty liver and a method for preparing same. The composition is prepared from the following hulk drugs by weight ratio: 8.75-60 parts of silibinin, 15-65 parts of phospholipid, 25-200 parts of Pu'er tea extract, and 5-50 parts of radix puerariae extract.Type: GrantFiled: March 22, 2016Date of Patent: August 13, 2019Assignee: Tasly Pharmaceutical Group Co., Ltd.Inventors: Xijun Yan, Naifeng Wu, He Sun, Kaijing Yan, Yonghong Zhu, Xiaohui Ma, Shunnan Zhang, Changwen Li, Xiaolin Bai, Ting Li, Lei Li, Yi He
-
Patent number: 10376490Abstract: A pharmaceutical composition for treating non-alcoholic fatty liver diseases consists of a silybin-phospholipid complex preparation and Pu'er tea/tea product according to a weight ratio of 0.5-2.5:0.3-10, wherein the silybin-phospholipid complex capsule preparation and the Pu'er teat/tea product are separately packaged.Type: GrantFiled: March 22, 2016Date of Patent: August 13, 2019Assignee: Tasly Pharmaceutical Group Co., Ltd.Inventors: Naifeng Wu, Xijun Yan, He Sun, Kaijing Yan, Yonghong Zhu, Shunnan Zhang, Xiaolin Bai, Yi He, Xiaohui Ma, Ting Li
-
Patent number: 10307396Abstract: A pharmaceutical composition. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 8.75-60 parts of silybin, 15-65 parts of phospholipid, 25-200 parts of a Pu'er tea extract, 6.25-40 parts of vitamin E, and 8.3-60 parts of L-carnitine. The composition can be used for treating non-alcoholic fatty liver diseases.Type: GrantFiled: March 22, 2016Date of Patent: June 4, 2019Assignee: Tasly Pharmaceutical Group Co., Ltd.Inventors: He Sun, Xijun Yan, Naifeng Wu, Kaijing Yan, Yonghong Zhu, Shunnan Zhang, Xiaolin Bai, Xiaohui Ma, Yi He, Ting Li, Lei Li
-
Patent number: 10307395Abstract: A pharmaceutical composition for treating non-alcoholic fatty liver diseases. The pharmaceutical composition is prepared from 8.75-60 parts by weight of silybin, 15-65 parts by weight of phospholipid, 25-150 parts by weight of a Pu'er tea extract, and 10.425-60 parts by weight of L-carnitine.Type: GrantFiled: March 22, 2016Date of Patent: June 4, 2019Assignee: Tasly Pharmaceutical Group Co., Ltd.Inventors: He Sun, Xijun Yan, Naifeng Wu, Kaijing Yan, Yonghong Zhu, Shunnan Zhang, Xiaolin Bai, Xiaohui Ma, Yi He, Ting Li, Lei Li
-
Publication number: 20180104215Abstract: A pharmaceutical composition for treating non-alcoholic fatty liver diseases. The pharmaceutical composition is prepared from 8.75-60 parts by weight of silybin, 15-65 parts by weight of phospholipid, 25-150 parts by weight of a Pu'er tea extract, and 10.425-60 parts by weight of L-carnitine.Type: ApplicationFiled: March 22, 2016Publication date: April 19, 2018Inventors: He SUN, Xijun YAN, Naifeng WU, Kaijing YAN, Yonghong ZHU, Shunnan ZHANG, Xiaolin BAI, Xiaohui MA, Yi HE, Ting LI, Lei LI
-
Publication number: 20180104216Abstract: Disclosed are a pharmaceutical composition for treating non-alcoholic fatty liver and a method for preparing same. The composition is prepared from the following hulk drugs by weight ratio: 8.75-60 parts of silibinin, 15-65 parts of phospholipid, 25-200 parts of Pu'er tea extract, and 5-50 parts of radix puerariae extract.Type: ApplicationFiled: March 22, 2016Publication date: April 19, 2018Inventors: Xijun YAN, Naifeng WU, He SUN, Kaijing YAN, Yonghong ZHU, Xiaohui MA, Shunnan ZHANG, Changwen LI, Xiaolin BAI, Ting LI, Lei LI, Yi HE
-
Publication number: 20180055817Abstract: A pharmaceutical composition. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 8.75-60 parts of silybin, 15-65 parts of phospholipid, 25-200 parts of a Pu'er tea extract, 6.25-40 parts of vitamin E, and 8.3-60 parts of L-carnitine. The composition can be used for treating non-alcoholic fatty liver diseases.Type: ApplicationFiled: March 22, 2016Publication date: March 1, 2018Inventors: He SUN, Xijun YAN, Naifeng WU, Kaijing YAN, Yonghong ZHU, Shunnan ZHANG, Xiaolin BAI, Xiaohui MA, Yi HE, Ting LI, Lei LI
-
Publication number: 20180050015Abstract: A pharmaceutical composition is prepared from the following raw materials (in parts by weight): silybin (8.75-60), phospholipid (15-65), a Pu'er tea extract (25-200), and vitamin E (6.25-40). The composition has the effect of treating non-alcoholic fatty liver diseases.Type: ApplicationFiled: March 22, 2016Publication date: February 22, 2018Inventors: He SUN, Xijun YAN, Naifeng WU, Kaijing YAN, Yonghong ZHU, Shunnan ZHANG, Xiaolin BAI, XIaohui MA, Yi HE, Ting LI, Lei LI
-
Publication number: 20180042892Abstract: Disclosed is a pharmaceutical composition containing silibinin, which is prepared from the following bulk drugs by weight ratio: 8.75-60 parts of silibinin, 15-65 parts of phospholipid, and 25-200 parts of Pu'er tea extract. The drug has the function of treating non-alcoholic fatty liver.Type: ApplicationFiled: March 22, 2016Publication date: February 15, 2018Inventors: Naifeng WU, Xijun YAN, He SUN, Kaijing YAN, Yonghong ZHU, Shunnan ZHANG, Xiaolin BAI, Yi HE, Xiaohui MA, Ting LI, Lei LI
-
Publication number: 20180042893Abstract: A pharmaceutical composition for treating non-alcoholic fatty liver diseases consists of a silybin-phospholipid complex preparation and Pu'er tea/tea product according to a weight ratio of 0.5-2.5:0.3-10, wherein the silybin-phospholipid complex capsule preparation and the Pu'er teat/tea product are separately packaged.Type: ApplicationFiled: March 22, 2016Publication date: February 15, 2018Inventors: Naifeng WU, Xijun YAN, He SUN, Kaijirig YAN, Yonghong ZHU, Shunnan ZHANG, Xiaolin BAI, Yi HE, Xiaohni MA, Ting LI
-
Patent number: 9795648Abstract: A pharmaceutical composition for treating headache, prepared from eleven Chinese herbal medicines: Chinese angelica root, ligusticum chuanxiong, radix paeoniae lactiflorae, prepared rhizome of rehmannia, uncaria tomentosa, leatherleaf milletia, prunella vulgaris, sicklesenna seed, pearl shell, corydalis tuber, and asarum, and a proper amount of adjuvant materials. A preparation method of the pharmaceutical composition, and uses thereof in the preparation of drugs for treating various headaches, traumatic cranial nerve syndrome, dizziness and vertigo, vexation and irritability, insomnia and dreaminess.Type: GrantFiled: December 19, 2013Date of Patent: October 24, 2017Assignee: Tasly Pharmaceutical Group Co., Ltd.Inventors: Xijun Yan, Naifeng Wu, Shunnan Zhang, Jianhui Yang, Yan Liu, Xingyun Shao, Song Gao, Lina Dong, Xiaolin Bai, Yan Sun, Bo Xu, Yongfeng Zheng, Lijun Fan
-
Publication number: 20150352168Abstract: A pharmaceutical composition for treating headache, prepared from eleven Chinese herbal medicines: Chinese angelica root, ligusticum chuanxiong, radix paeoniae lactiflorae, prepared rhizome of rehmannia, uncaria tomentosa, leatherleaf milletia, prunella vulgaris, sicklesenna seed, pearl shell, corydalis tuber, and asarum, and a proper amount of adjuvant materials. A preparation method of the pharmaceutical composition, and uses thereof in the preparation of drugs for treating various headaches, traumatic cranial nerve syndrome, dizziness and vertigo, vexation and irritability, insomnia and dreaminess.Type: ApplicationFiled: December 19, 2013Publication date: December 10, 2015Applicant: Tasly Pharmaceutical Group Co., Ltd.Inventors: Xijun YAN, Naifeng WU, Shunnan ZHANG, Jianhui YANG, Yan LIU, Xingyun SHAO, Song GAO, Lina DONG, Xiaolin BAI, Yan SUN, Bo XU, Yongfeng ZHENG, Lijun FAN
-
Patent number: 8951568Abstract: A pharmaceutical granule whose shape is spherical or sphere-like shape with a bulk density of 0.6-1.3 g/ml and a dissolution time of 0.5-5 minutes, which is prepared as follows: mother granules are filled into a fluidized-bed as bed charge; active pharmaceutical ingredients are prepared into a suspension or solution whose viscosity is adjusted to 6.0-9.8 Mpa·S with viscosity adjusting agent; then it is sprayed onto surface of said mother granule to obtain final granule.Type: GrantFiled: June 22, 2007Date of Patent: February 10, 2015Assignee: Tasly Pharmaceuticals Group Co., Ltd.Inventors: Shunnan Zhang, Jianhui Yang, Lina Dong, Hongbo Zhang, Xiaolin Bai, Yan Sun, Ting Li
-
Patent number: 8622174Abstract: An escape device for high-rise buildings includes an escape capsule, a speedup gear mounted to the escape capsule, a track provided with a rack with which the speedup gear is engaged so that the escape capsule can move along the track, and a damper including a rotor. The speedup gear in operation drives the rotor into rotation and the damper is capable of converting a portion of kinetic energy of the escape capsule to the electric energy. The escape device can be braked at any position at a building.Type: GrantFiled: March 2, 2009Date of Patent: January 7, 2014Inventor: Xiaolin Bai
-
Publication number: 20110042167Abstract: An escape device for high-rise buildings includes an escape capsule, a speedup gear mounted to the escape capsule, a track provided with a rack with which the speedup gear is engaged so that the escape capsule can move along the track, and a damper including a rotor. The speedup gear in operation drives the rotor into rotation and the damper is capable of converting a portion of kinetic energy of the escape capsule to the electric energy. The escape device can be braked at any position at a building.Type: ApplicationFiled: March 2, 2009Publication date: February 24, 2011Inventor: Xiaolin Bai
-
Publication number: 20100009000Abstract: A pharmaceutical granule whose shape is spherical or sphere-like shape with a bulk density of 0.6-1.3 g/ml and a dissolution time of 0.5-5 minutes, which is prepared as follows: mother granules are filled into a fluidized-bed as bed charge; active pharmaceutical ingredients are prepared into a suspension or solution whose viscosity is adjusted to 6.0-9.8 Mpa·S with viscosity adjusting agent; then it is sprayed onto surface of said mother granule to obtain final granule.Type: ApplicationFiled: June 22, 2007Publication date: January 14, 2010Applicant: TIANJIN TASLY PHARMACEUTICAL CO. LTD.Inventors: Shunnan Zhang, Jianhui Yang, Lina Dong, Hongbo Zhang, Xiaolin Bai, Yan Sun, Ting Li